November, 2024

Yahoo Finance

Corstasis Therapeutics to Present Pivotal Trial Data on Novel Bumetanide Nasal Spray at American Heart Association Scientific Sessions 2024

Read More

November, 2024

Cardiovascular Research Foundation

Nasal Bumetanide Safe, Effective in Healthy Adults

Read More

November, 2024

American College of Cardiology

RSQ-777-02: New Nasal Spray Form of Bumetanide as Effective as Oral and IV Forms in Patients Without HF or HF Risk

Read More

November, 2024

American Heart Association

Nasal spray version of common diuretic has potential to help treat heart failure

Read More

June, 2023

Medium

TRITON FUNDS Fuels Innovation in Heart Failure Therapies with Strategic Investment in Corstasis Therapeutics

Read More

April, 2023

National Library of Medicine

Novel Intranasal Loop Diuretic

Read More

January, 2023

IssueWire

Corstasis Therapeutic Presenting at BIOTECH SHOWCASE™

Read More